| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 79 | 2024 | 2303 | 14.360 |
Why?
|
| Florida | 76 | 2024 | 410 | 6.940 |
Why?
|
| Anti-HIV Agents | 13 | 2024 | 420 | 5.840 |
Why?
|
| Residence Characteristics | 23 | 2022 | 322 | 5.470 |
Why?
|
| Viral Load | 18 | 2024 | 312 | 4.380 |
Why?
|
| Emigrants and Immigrants | 11 | 2021 | 137 | 3.050 |
Why?
|
| Healthcare Disparities | 10 | 2018 | 494 | 3.050 |
Why?
|
| Continuity of Patient Care | 7 | 2020 | 94 | 2.750 |
Why?
|
| Mass Screening | 14 | 2019 | 462 | 2.690 |
Why?
|
| Humans | 151 | 2024 | 37093 | 2.670 |
Why?
|
| Homosexuality, Male | 9 | 2022 | 458 | 2.630 |
Why?
|
| Adolescent | 66 | 2022 | 5363 | 2.580 |
Why?
|
| Adult | 88 | 2024 | 11712 | 2.560 |
Why?
|
| Acquired Immunodeficiency Syndrome | 8 | 2024 | 215 | 2.560 |
Why?
|
| Female | 110 | 2024 | 20969 | 2.530 |
Why?
|
| Poverty | 13 | 2024 | 348 | 2.420 |
Why?
|
| Male | 93 | 2024 | 20025 | 2.140 |
Why?
|
| Population Surveillance | 14 | 2019 | 238 | 1.900 |
Why?
|
| Young Adult | 42 | 2022 | 4268 | 1.880 |
Why?
|
| Patient-Centered Care | 2 | 2024 | 63 | 1.800 |
Why?
|
| Haiti | 8 | 2024 | 68 | 1.740 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2021 | 11 | 1.730 |
Why?
|
| Depression, Postpartum | 3 | 2017 | 10 | 1.710 |
Why?
|
| Middle Aged | 51 | 2024 | 10129 | 1.660 |
Why?
|
| Food Handling | 6 | 2010 | 33 | 1.650 |
Why?
|
| Urban Population | 11 | 2021 | 333 | 1.630 |
Why?
|
| Rural Health | 5 | 2016 | 53 | 1.560 |
Why?
|
| Prenatal Care | 4 | 2017 | 73 | 1.510 |
Why?
|
| Anomie | 2 | 2021 | 6 | 1.500 |
Why?
|
| Qualitative Research | 6 | 2024 | 446 | 1.500 |
Why?
|
| Health Education | 7 | 2019 | 338 | 1.480 |
Why?
|
| United States | 28 | 2024 | 4223 | 1.480 |
Why?
|
| Health Status Disparities | 6 | 2021 | 642 | 1.430 |
Why?
|
| Stress, Psychological | 7 | 2024 | 583 | 1.410 |
Why?
|
| Risk Factors | 31 | 2022 | 3562 | 1.390 |
Why?
|
| Retrospective Studies | 19 | 2024 | 2026 | 1.370 |
Why?
|
| Delayed Diagnosis | 5 | 2017 | 28 | 1.360 |
Why?
|
| Substance-Related Disorders | 11 | 2024 | 730 | 1.270 |
Why?
|
| Consumer Product Safety | 4 | 2008 | 10 | 1.230 |
Why?
|
| Socioeconomic Factors | 16 | 2024 | 1067 | 1.210 |
Why?
|
| Social Environment | 2 | 2019 | 207 | 1.190 |
Why?
|
| Public Assistance | 6 | 2010 | 27 | 1.160 |
Why?
|
| Rural Population | 9 | 2021 | 294 | 1.160 |
Why?
|
| Risk-Taking | 13 | 2020 | 451 | 1.110 |
Why?
|
| Minority Groups | 9 | 2024 | 596 | 1.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2019 | 864 | 1.080 |
Why?
|
| Logistic Models | 15 | 2019 | 923 | 1.040 |
Why?
|
| Anti-Retroviral Agents | 5 | 2023 | 147 | 1.010 |
Why?
|
| Prevalence | 13 | 2021 | 1455 | 1.000 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2019 | 103 | 0.990 |
Why?
|
| Foodborne Diseases | 3 | 2010 | 22 | 0.990 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 404 | 0.970 |
Why?
|
| Depression | 3 | 2019 | 712 | 0.930 |
Why?
|
| Cross-Sectional Studies | 19 | 2024 | 2721 | 0.930 |
Why?
|
| Bayes Theorem | 1 | 2024 | 94 | 0.930 |
Why?
|
| Medication Adherence | 5 | 2023 | 179 | 0.870 |
Why?
|
| Gonorrhea | 2 | 2021 | 24 | 0.860 |
Why?
|
| Food Services | 5 | 2010 | 31 | 0.850 |
Why?
|
| Social Class | 4 | 2018 | 247 | 0.820 |
Why?
|
| Physicians | 1 | 2024 | 163 | 0.820 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 198 | 0.810 |
Why?
|
| Vaccination | 7 | 2024 | 288 | 0.810 |
Why?
|
| Parents | 3 | 2019 | 329 | 0.810 |
Why?
|
| Delivery of Health Care | 3 | 2024 | 276 | 0.810 |
Why?
|
| Professional-Patient Relations | 2 | 2023 | 48 | 0.790 |
Why?
|
| Urban Health | 5 | 2016 | 95 | 0.790 |
Why?
|
| Asthma | 4 | 2017 | 380 | 0.780 |
Why?
|
| Odds Ratio | 11 | 2018 | 534 | 0.780 |
Why?
|
| Child, Preschool | 21 | 2017 | 1418 | 0.780 |
Why?
|
| Pregnancy | 14 | 2022 | 1549 | 0.770 |
Why?
|
| Pregnant Women | 3 | 2022 | 48 | 0.760 |
Why?
|
| Cause of Death | 4 | 2016 | 156 | 0.760 |
Why?
|
| Chlamydia | 1 | 2021 | 42 | 0.750 |
Why?
|
| Unsafe Sex | 5 | 2019 | 161 | 0.750 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 72 | 0.720 |
Why?
|
| Triage | 1 | 2020 | 26 | 0.710 |
Why?
|
| Mercury | 2 | 2017 | 39 | 0.710 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 49 | 0.700 |
Why?
|
| Environmental Exposure | 4 | 2017 | 216 | 0.700 |
Why?
|
| Ambulatory Care Facilities | 3 | 2009 | 61 | 0.690 |
Why?
|
| Sexual Behavior | 9 | 2020 | 609 | 0.680 |
Why?
|
| Chlamydia Infections | 2 | 2019 | 196 | 0.670 |
Why?
|
| Health Services Accessibility | 6 | 2021 | 560 | 0.660 |
Why?
|
| Patient Compliance | 1 | 2020 | 212 | 0.630 |
Why?
|
| Infant | 14 | 2022 | 1046 | 0.620 |
Why?
|
| Child | 23 | 2019 | 3131 | 0.620 |
Why?
|
| Infant, Newborn | 11 | 2022 | 894 | 0.610 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 205 | 0.580 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2017 | 12 | 0.580 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 16 | 0.580 |
Why?
|
| Risk Assessment | 5 | 2016 | 753 | 0.580 |
Why?
|
| Sexually Transmitted Diseases | 5 | 2018 | 164 | 0.570 |
Why?
|
| Life Change Events | 1 | 2016 | 92 | 0.550 |
Why?
|
| Death Certificates | 1 | 2015 | 12 | 0.530 |
Why?
|
| Substance Abuse, Intravenous | 4 | 2020 | 121 | 0.510 |
Why?
|
| Multilevel Analysis | 4 | 2019 | 16 | 0.510 |
Why?
|
| Lead Poisoning | 3 | 2005 | 26 | 0.510 |
Why?
|
| Health Personnel | 3 | 2024 | 228 | 0.510 |
Why?
|
| Disease Notification | 2 | 2008 | 6 | 0.500 |
Why?
|
| Program Evaluation | 3 | 2020 | 339 | 0.490 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 336 | 0.460 |
Why?
|
| Social Support | 4 | 2024 | 394 | 0.450 |
Why?
|
| beta-Lactamases | 3 | 2021 | 33 | 0.430 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 352 | 0.420 |
Why?
|
| Sexual Partners | 5 | 2021 | 314 | 0.420 |
Why?
|
| Aged | 16 | 2024 | 6741 | 0.420 |
Why?
|
| Cuba | 4 | 2019 | 32 | 0.410 |
Why?
|
| HIV | 2 | 2018 | 98 | 0.400 |
Why?
|
| Cross Infection | 3 | 2020 | 38 | 0.400 |
Why?
|
| Public Health Administration | 3 | 2009 | 26 | 0.390 |
Why?
|
| Cohort Studies | 6 | 2021 | 1492 | 0.390 |
Why?
|
| Longitudinal Studies | 6 | 2019 | 885 | 0.390 |
Why?
|
| Housing | 3 | 2022 | 59 | 0.390 |
Why?
|
| Neoplasms | 2 | 2019 | 1103 | 0.380 |
Why?
|
| Age Factors | 7 | 2020 | 1033 | 0.370 |
Why?
|
| Biomedical Research | 3 | 2021 | 400 | 0.370 |
Why?
|
| Proportional Hazards Models | 5 | 2016 | 441 | 0.360 |
Why?
|
| Maternal-Child Health Centers | 1 | 2010 | 4 | 0.360 |
Why?
|
| Caribbean Region | 3 | 2021 | 69 | 0.360 |
Why?
|
| Multimedia | 1 | 2010 | 17 | 0.360 |
Why?
|
| Demography | 3 | 2019 | 175 | 0.340 |
Why?
|
| Hepacivirus | 2 | 2007 | 62 | 0.340 |
Why?
|
| Voluntary Programs | 1 | 2009 | 4 | 0.340 |
Why?
|
| Sentinel Surveillance | 1 | 2009 | 21 | 0.340 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 145 | 0.330 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2015 | 221 | 0.330 |
Why?
|
| Awareness | 3 | 2018 | 65 | 0.330 |
Why?
|
| Sex Factors | 4 | 2024 | 898 | 0.320 |
Why?
|
| Students | 4 | 2018 | 519 | 0.320 |
Why?
|
| Interviews as Topic | 3 | 2024 | 381 | 0.320 |
Why?
|
| Hepatitis C Antibodies | 2 | 2007 | 10 | 0.310 |
Why?
|
| Sex Distribution | 4 | 2015 | 215 | 0.310 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 32 | 0.310 |
Why?
|
| Risk Reduction Behavior | 3 | 2019 | 127 | 0.310 |
Why?
|
| Hepatitis B Vaccines | 2 | 2007 | 14 | 0.310 |
Why?
|
| Survival Rate | 3 | 2014 | 311 | 0.310 |
Why?
|
| Refugees | 2 | 2005 | 19 | 0.310 |
Why?
|
| Health Policy | 2 | 2021 | 165 | 0.300 |
Why?
|
| Health Services Research | 1 | 2008 | 148 | 0.300 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 208 | 0.290 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2006 | 6 | 0.290 |
Why?
|
| Hepatitis C, Chronic | 1 | 2007 | 39 | 0.290 |
Why?
|
| Safe Sex | 4 | 2020 | 76 | 0.290 |
Why?
|
| Syphilis | 1 | 2006 | 23 | 0.280 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 540 | 0.280 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 2379 | 0.270 |
Why?
|
| Alcohol Drinking | 4 | 2016 | 519 | 0.270 |
Why?
|
| Incidence | 8 | 2015 | 922 | 0.270 |
Why?
|
| Emigration and Immigration | 2 | 2006 | 82 | 0.260 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 583 | 0.260 |
Why?
|
| Condoms | 5 | 2019 | 135 | 0.250 |
Why?
|
| Vital Statistics | 2 | 2017 | 7 | 0.250 |
Why?
|
| Perception | 2 | 2024 | 195 | 0.240 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 151 | 0.240 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2003 | 11 | 0.240 |
Why?
|
| Hepatitis B virus | 1 | 2003 | 13 | 0.240 |
Why?
|
| Hepatitis B | 1 | 2003 | 38 | 0.230 |
Why?
|
| Disclosure | 1 | 2023 | 34 | 0.230 |
Why?
|
| Canada | 1 | 2023 | 130 | 0.230 |
Why?
|
| Drug Users | 2 | 2024 | 46 | 0.220 |
Why?
|
| Research Personnel | 2 | 2021 | 155 | 0.220 |
Why?
|
| Disease Outbreaks | 3 | 2003 | 155 | 0.220 |
Why?
|
| Latin America | 2 | 2021 | 45 | 0.220 |
Why?
|
| Disabled Persons | 1 | 2023 | 65 | 0.220 |
Why?
|
| Time Factors | 4 | 2019 | 1742 | 0.220 |
Why?
|
| HIV Seropositivity | 2 | 2015 | 190 | 0.210 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 935 | 0.210 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 400 | 0.210 |
Why?
|
| South America | 2 | 2019 | 15 | 0.200 |
Why?
|
| Population Density | 2 | 2020 | 23 | 0.200 |
Why?
|
| Prediabetic State | 1 | 2022 | 53 | 0.200 |
Why?
|
| Administrative Personnel | 1 | 2021 | 10 | 0.200 |
Why?
|
| Mothers | 2 | 2016 | 181 | 0.190 |
Why?
|
| Mexico | 3 | 2017 | 240 | 0.190 |
Why?
|
| Intensive Care Units | 1 | 2021 | 59 | 0.190 |
Why?
|
| Drug Utilization | 1 | 2001 | 29 | 0.190 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 26 | 0.190 |
Why?
|
| Career Mobility | 1 | 2021 | 24 | 0.190 |
Why?
|
| Registries | 2 | 2020 | 335 | 0.190 |
Why?
|
| Information Dissemination | 1 | 2021 | 59 | 0.190 |
Why?
|
| Mental Health | 1 | 2024 | 303 | 0.190 |
Why?
|
| Faculty, Medical | 1 | 2021 | 66 | 0.190 |
Why?
|
| Respiratory Tract Infections | 1 | 2001 | 33 | 0.190 |
Why?
|
| Premature Birth | 1 | 2022 | 75 | 0.190 |
Why?
|
| Health Surveys | 3 | 2019 | 373 | 0.180 |
Why?
|
| Sex Characteristics | 1 | 2022 | 230 | 0.180 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 25 | 0.180 |
Why?
|
| Financing, Government | 1 | 2020 | 19 | 0.180 |
Why?
|
| Comorbidity | 3 | 2019 | 623 | 0.180 |
Why?
|
| Central America | 2 | 2017 | 9 | 0.180 |
Why?
|
| Salmonella enteritidis | 1 | 1999 | 1 | 0.180 |
Why?
|
| Eggs | 1 | 1999 | 7 | 0.180 |
Why?
|
| Educational Status | 3 | 2018 | 313 | 0.180 |
Why?
|
| Salmonella Infections | 1 | 1999 | 17 | 0.170 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 11 | 0.170 |
Why?
|
| Social Control, Informal | 1 | 2019 | 9 | 0.170 |
Why?
|
| Drug Evaluation | 1 | 2019 | 9 | 0.170 |
Why?
|
| Liver Diseases | 1 | 2019 | 33 | 0.170 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 22 | 0.170 |
Why?
|
| Drug Approval | 1 | 2019 | 8 | 0.170 |
Why?
|
| Lead | 2 | 1998 | 93 | 0.170 |
Why?
|
| Health Promotion | 4 | 2017 | 653 | 0.170 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 215 | 0.170 |
Why?
|
| Tobacco, Smokeless | 1 | 2018 | 18 | 0.170 |
Why?
|
| Pyridones | 1 | 2019 | 40 | 0.160 |
Why?
|
| Tuberculosis | 1 | 1999 | 63 | 0.160 |
Why?
|
| Confidence Intervals | 3 | 2011 | 149 | 0.160 |
Why?
|
| Health Behavior | 2 | 2022 | 537 | 0.160 |
Why?
|
| Pyrazoles | 1 | 2019 | 85 | 0.160 |
Why?
|
| Alcohol-Related Disorders | 2 | 2016 | 55 | 0.160 |
Why?
|
| Mass Media | 2 | 2008 | 35 | 0.160 |
Why?
|
| Health Facility Environment | 1 | 2018 | 4 | 0.160 |
Why?
|
| Case Management | 1 | 2018 | 20 | 0.160 |
Why?
|
| Water Pollutants, Chemical | 2 | 1998 | 164 | 0.150 |
Why?
|
| Individuality | 1 | 2018 | 46 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 204 | 0.150 |
Why?
|
| Marketing | 1 | 2017 | 40 | 0.150 |
Why?
|
| Developing Countries | 1 | 2018 | 99 | 0.150 |
Why?
|
| Wisconsin | 4 | 2001 | 8 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2019 | 167 | 0.150 |
Why?
|
| Child Health Services | 2 | 2008 | 43 | 0.150 |
Why?
|
| Age Distribution | 4 | 2019 | 225 | 0.150 |
Why?
|
| Health Services Misuse | 1 | 2017 | 12 | 0.150 |
Why?
|
| Public Health | 1 | 2021 | 372 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2011 | 643 | 0.140 |
Why?
|
| Spouses | 1 | 2017 | 30 | 0.140 |
Why?
|
| Adult Children | 1 | 2016 | 5 | 0.140 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 1996 | 4 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 664 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 1996 | 12 | 0.140 |
Why?
|
| HIV Seroprevalence | 1 | 1996 | 14 | 0.140 |
Why?
|
| Medical Record Linkage | 1 | 1996 | 16 | 0.140 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 59 | 0.140 |
Why?
|
| Puerto Rico | 2 | 2018 | 1378 | 0.130 |
Why?
|
| Gender Identity | 1 | 2016 | 103 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2017 | 167 | 0.130 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2015 | 41 | 0.130 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 17 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2015 | 64 | 0.130 |
Why?
|
| Poverty Areas | 1 | 2015 | 41 | 0.130 |
Why?
|
| Inpatients | 1 | 1996 | 74 | 0.130 |
Why?
|
| Papillomavirus Infections | 2 | 2017 | 336 | 0.130 |
Why?
|
| Child Abuse | 1 | 2016 | 79 | 0.130 |
Why?
|
| Minority Health | 1 | 2015 | 88 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2014 | 38 | 0.120 |
Why?
|
| Environmental Pollutants | 1 | 1997 | 179 | 0.120 |
Why?
|
| Primary Prevention | 1 | 2014 | 59 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2015 | 210 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 485 | 0.120 |
Why?
|
| Arsenic | 1 | 1996 | 144 | 0.120 |
Why?
|
| Medical Records | 2 | 2006 | 41 | 0.120 |
Why?
|
| Mexican Americans | 1 | 2015 | 189 | 0.110 |
Why?
|
| Body Burden | 3 | 1997 | 10 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 189 | 0.110 |
Why?
|
| Mortality | 2 | 2011 | 145 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 225 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 1130 | 0.110 |
Why?
|
| Hypertension | 2 | 2017 | 796 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2013 | 325 | 0.100 |
Why?
|
| Hepatitis C | 2 | 2003 | 125 | 0.100 |
Why?
|
| United States Social Security Administration | 1 | 2011 | 4 | 0.100 |
Why?
|
| Exercise | 1 | 2017 | 613 | 0.100 |
Why?
|
| Workload | 1 | 2011 | 22 | 0.100 |
Why?
|
| Focus Groups | 2 | 2017 | 348 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 191 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 2 | 2022 | 39 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2011 | 79 | 0.090 |
Why?
|
| Computer-Assisted Instruction | 1 | 2010 | 25 | 0.090 |
Why?
|
| Self Efficacy | 2 | 2022 | 184 | 0.090 |
Why?
|
| Data Collection | 1 | 2010 | 194 | 0.090 |
Why?
|
| Nutritional Sciences | 1 | 2009 | 22 | 0.090 |
Why?
|
| Food Contamination | 1 | 2010 | 55 | 0.090 |
Why?
|
| Malawi | 2 | 2020 | 9 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2016 | 517 | 0.090 |
Why?
|
| Public Health Informatics | 1 | 2009 | 8 | 0.090 |
Why?
|
| Diarrhea | 1 | 2009 | 89 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2011 | 353 | 0.080 |
Why?
|
| Communication | 2 | 2021 | 180 | 0.080 |
Why?
|
| Random Allocation | 2 | 2016 | 139 | 0.080 |
Why?
|
| Germany | 3 | 1998 | 24 | 0.080 |
Why?
|
| Louisiana | 2 | 2019 | 43 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2009 | 208 | 0.080 |
Why?
|
| Education | 1 | 2008 | 55 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2018 | 455 | 0.080 |
Why?
|
| Universities | 2 | 2008 | 442 | 0.080 |
Why?
|
| Program Development | 1 | 2009 | 233 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2008 | 195 | 0.080 |
Why?
|
| Hepatitis A Vaccines | 1 | 2007 | 6 | 0.070 |
Why?
|
| School Health Services | 1 | 2008 | 81 | 0.070 |
Why?
|
| Caregivers | 1 | 2010 | 182 | 0.070 |
Why?
|
| Water Supply | 2 | 1998 | 57 | 0.070 |
Why?
|
| Food Microbiology | 1 | 2007 | 34 | 0.070 |
Why?
|
| Maternal Health Services | 1 | 2006 | 13 | 0.070 |
Why?
|
| Population Dynamics | 1 | 2006 | 35 | 0.070 |
Why?
|
| Blood-Borne Pathogens | 2 | 2003 | 7 | 0.070 |
Why?
|
| Video Recording | 1 | 2006 | 32 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2008 | 550 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 2006 | 40 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 661 | 0.070 |
Why?
|
| Rubella Vaccine | 1 | 2006 | 2 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2006 | 84 | 0.070 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2006 | 2 | 0.070 |
Why?
|
| Counseling | 1 | 2007 | 116 | 0.070 |
Why?
|
| Postnatal Care | 1 | 2006 | 13 | 0.070 |
Why?
|
| Community Health Services | 1 | 2006 | 185 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2022 | 1378 | 0.060 |
Why?
|
| Schools | 2 | 2017 | 260 | 0.060 |
Why?
|
| Alcoholism | 1 | 2007 | 240 | 0.060 |
Why?
|
| Trinidad and Tobago | 1 | 2023 | 3 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2003 | 26 | 0.060 |
Why?
|
| Organ Transplantation | 1 | 2003 | 18 | 0.060 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2023 | 57 | 0.060 |
Why?
|
| Hospital Units | 1 | 2003 | 3 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2023 | 63 | 0.060 |
Why?
|
| Equipment Contamination | 1 | 2003 | 5 | 0.060 |
Why?
|
| Syringes | 1 | 2003 | 6 | 0.060 |
Why?
|
| Child Welfare | 1 | 2003 | 42 | 0.050 |
Why?
|
| Salmonella Food Poisoning | 1 | 2002 | 1 | 0.050 |
Why?
|
| West Nile Fever | 1 | 2003 | 56 | 0.050 |
Why?
|
| West Nile virus | 1 | 2003 | 65 | 0.050 |
Why?
|
| Salmonella typhi | 1 | 2002 | 33 | 0.050 |
Why?
|
| Typhoid Fever | 1 | 2002 | 46 | 0.050 |
Why?
|
| Birth Weight | 1 | 2022 | 90 | 0.050 |
Why?
|
| Colorado | 2 | 2002 | 15 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| Ambulatory Care | 2 | 2017 | 75 | 0.050 |
Why?
|
| Meningitis, Haemophilus | 1 | 2000 | 1 | 0.050 |
Why?
|
| Haemophilus Vaccines | 1 | 2000 | 3 | 0.050 |
Why?
|
| Fruit | 1 | 2002 | 173 | 0.050 |
Why?
|
| Carbapenems | 1 | 2020 | 8 | 0.050 |
Why?
|
| Enterobacteriaceae | 1 | 2020 | 28 | 0.040 |
Why?
|
| Salmonella Phages | 1 | 1999 | 1 | 0.040 |
Why?
|
| Hospital Records | 1 | 1999 | 4 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 140 | 0.040 |
Why?
|
| Serotyping | 1 | 1999 | 36 | 0.040 |
Why?
|
| Sample Size | 1 | 2019 | 25 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 86 | 0.040 |
Why?
|
| Philadelphia | 1 | 2019 | 15 | 0.040 |
Why?
|
| Health Status | 1 | 2003 | 380 | 0.040 |
Why?
|
| Restaurants | 1 | 1999 | 39 | 0.040 |
Why?
|
| Patient Discharge | 1 | 1999 | 93 | 0.040 |
Why?
|
| Psychometrics | 1 | 2021 | 318 | 0.040 |
Why?
|
| Chickens | 1 | 1999 | 133 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 1095 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2019 | 102 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 291 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 1998 | 55 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2017 | 46 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 562 | 0.040 |
Why?
|
| Drinking | 1 | 1998 | 38 | 0.040 |
Why?
|
| Eritrea | 1 | 2017 | 1 | 0.040 |
Why?
|
| Government | 1 | 2017 | 6 | 0.040 |
Why?
|
| Skin Tests | 1 | 1997 | 14 | 0.040 |
Why?
|
| Chemical Industry | 1 | 1997 | 2 | 0.040 |
Why?
|
| Medicine, Traditional | 1 | 2017 | 23 | 0.040 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1997 | 12 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 1997 | 37 | 0.040 |
Why?
|
| Coal Mining | 1 | 1997 | 7 | 0.040 |
Why?
|
| Environmental Pollution | 1 | 1997 | 18 | 0.040 |
Why?
|
| Alabama | 1 | 2017 | 51 | 0.040 |
Why?
|
| Mandatory Programs | 1 | 2016 | 4 | 0.040 |
Why?
|
| Virginia | 1 | 2016 | 10 | 0.040 |
Why?
|
| South Carolina | 1 | 2016 | 25 | 0.040 |
Why?
|
| Creatinine | 1 | 1997 | 103 | 0.040 |
Why?
|
| Germany, East | 1 | 1996 | 1 | 0.040 |
Why?
|
| Germany, West | 1 | 1996 | 1 | 0.040 |
Why?
|
| Tennessee | 1 | 2016 | 70 | 0.040 |
Why?
|
| Seasons | 1 | 2016 | 112 | 0.030 |
Why?
|
| Dust | 1 | 1997 | 54 | 0.030 |
Why?
|
| Physician's Role | 1 | 2016 | 38 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 1996 | 39 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1996 | 55 | 0.030 |
Why?
|
| Women's Health | 1 | 2017 | 145 | 0.030 |
Why?
|
| Arsenic Poisoning | 1 | 1996 | 6 | 0.030 |
Why?
|
| Poisoning | 1 | 1996 | 12 | 0.030 |
Why?
|
| Family | 1 | 2017 | 173 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 18 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 974 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 754 | 0.030 |
Why?
|
| Censuses | 1 | 2013 | 24 | 0.030 |
Why?
|
| Income | 1 | 2013 | 140 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2011 | 14 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 267 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 601 | 0.020 |
Why?
|
| Workplace | 1 | 2011 | 87 | 0.020 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 6 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 465 | 0.020 |
Why?
|
| Hygiene | 1 | 2009 | 14 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 160 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2011 | 242 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 236 | 0.020 |
Why?
|
| Single Person | 1 | 2007 | 5 | 0.020 |
Why?
|
| Rubella | 1 | 2006 | 15 | 0.020 |
Why?
|
| Blood Donors | 1 | 2003 | 17 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 40 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 7 | 0.010 |
Why?
|
| Viremia | 1 | 2003 | 42 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2003 | 30 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2003 | 42 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 82 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2003 | 44 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 55 | 0.010 |
Why?
|
| Physical Examination | 1 | 2003 | 43 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 91 | 0.010 |
Why?
|
| Animals | 1 | 1999 | 15081 | 0.010 |
Why?
|
| Frozen Foods | 1 | 2002 | 1 | 0.010 |
Why?
|
| Honduras | 1 | 2002 | 7 | 0.010 |
Why?
|
| Guatemala | 1 | 2002 | 17 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2002 | 27 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 86 | 0.010 |
Why?
|
| Feces | 1 | 2002 | 111 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2002 | 186 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 623 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2003 | 301 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 262 | 0.010 |
Why?
|
| Meningitis, Bacterial | 1 | 2000 | 9 | 0.010 |
Why?
|
| Government Programs | 1 | 2000 | 29 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 730 | 0.010 |
Why?
|
| Residual Volume | 1 | 1998 | 3 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1998 | 6 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 1998 | 11 | 0.010 |
Why?
|
| Common Cold | 1 | 1998 | 6 | 0.010 |
Why?
|
| Cough | 1 | 1998 | 18 | 0.010 |
Why?
|
| Mining | 1 | 1998 | 18 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1998 | 70 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1998 | 129 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1997 | 30 | 0.010 |
Why?
|
| Allergens | 1 | 1997 | 63 | 0.010 |
Why?
|